{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"KIT, a receptor tyrosine kinase, is recurrently mutated in gastrointestinal stromal tumors.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"02/03/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "23020152",
        "29360550"
      ]
    },
    "description":"The KIT R888Q mutation is located in the kinase domain of the protein. This mutation has been identified in biliary tract adenocarcinoma and is a statistically significant hotspot (PMID: 29360550). In vitro studies with melanoma cell lines expressing KIT R888Q demonstrate that the mutation is inactivating as measured by decreased SCF-induced activation compared to wildtype (PMID: 23020152).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Neutral",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"R888Q",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":3815,
    "hgvs":"4:g.54736787G>A",
    "hugoSymbol":"KIT",
    "id":null,
    "proteinEnd":888,
    "proteinStart":888,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The KIT R888Q mutation is likely neutral.",
  "vus":false
}